About Cybiocare

Founded in 2001, Cybiocare specializes in the development
of non-invasive photonic medical devices.

 

Its mission: to improve the quality of life for the over 300 million people
with diabetes around the world.

The company’s flagship product, the Photonic Glucose Sensor (PGS), is a revolutionary device that uses patented core photonics technology to non-invasively detect fluctuations in glucose levels, thus helping diabetics and their caregivers prevent hypoglycemia. Cybiocare partners with blood-glucose-meter suppliers and insulin pump manufacturers worldwide to provide complementary, value-added features for their diabetic clienteles.

Cybiocare has an expanding patent portfolio covering the unique aspects of the PGS, and which can be transposed to other diagnostic applications.

For more information, please contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

 

Cybiocare - Photonic medical device
© 2010 CYBIOCARE. All Rights Reserved. Conception : jfLarouche agence de publicité
Notice: PGS is an investigational device that has not been licensed in accordance with applicable laws in Canada and in other countries. PGS is currently subject to investigational testing in Canada for to assess the safety and efficacy of this device. The commercialization, distribution and sale of this investigational medical device have not yet been approved in any country.